2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task …
GF Tomaselli, KW Mahaffey, A Cuker… - Journal of the American …, 2017 - jacc.org
The American College of Cardiology (ACC) develops a number of policy documents to
provide members with guidance on clinical topics. Although clinical practice guidelines …
provide members with guidance on clinical topics. Although clinical practice guidelines …
2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution …
GF Tomaselli, KW Mahaffey, A Cuker… - Journal of the American …, 2020 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing …
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules
P Loewen, K Dahri - Annals of hematology, 2011 - Springer
This study aimed to determine whether progress in developing bleeding risk estimation tools
for patients on oral anticoagulant therapy has been made since 2006 when we last …
for patients on oral anticoagulant therapy has been made since 2006 when we last …
[HTML][HTML] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PloS one, 2018 - journals.plos.org
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry
M Ruiz Ortiz, J Muñiz, P Raña Míguez, I Roldán… - Ep …, 2018 - academic.oup.com
Aims To describe the prevalence and associated factors of inappropriate doses of direct oral
anticoagulants (DOAC) in a national registry of patients of real clinical practice. Methods and …
anticoagulants (DOAC) in a national registry of patients of real clinical practice. Methods and …
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum
DA Garcia, DM Witt, E Hylek… - Annals of …, 2008 - journals.sagepub.com
Objective: To provide recommendations, policies, and procedures pertaining to the provision
of optimized anticoagulation therapy designed to achieve desired clinical endpoints while …
of optimized anticoagulation therapy designed to achieve desired clinical endpoints while …
Pros and cons of new oral anticoagulants
KA Bauer - Hematology 2013, the American Society of …, 2013 - ashpublications.org
The availability of new oral anticoagulants (NOACs) targeting either thrombin (dabigatran
etexilate) or factor Xa (rivaroxaban and apixaban) for the prevention and treatment of …
etexilate) or factor Xa (rivaroxaban and apixaban) for the prevention and treatment of …
Reimagining anticoagulation clinics in the era of direct oral anticoagulants
Anticoagulation clinics were initially developed to provide safe and effective care for warfarin-
treated patients with atrial fibrillation, venous thromboembolism, and mechanical valve …
treated patients with atrial fibrillation, venous thromboembolism, and mechanical valve …
[HTML][HTML] Trends in prescribing oral anticoagulants in Canada, 2008–2014
JI Weitz, W Semchuk, AGG Turpie, WD Fisher… - Clinical …, 2015 - Elsevier
Purpose The non–vitamin K antagonist oral anticoagulants (NOACs), dabigatran,
rivaroxaban, and apixaban, provide several advantages over vitamin K antagonists, such as …
rivaroxaban, and apixaban, provide several advantages over vitamin K antagonists, such as …